Affordable Access

Therapeutic drug monitoring of A77 1726, the active metabolite of leflunomide: serum concentrations predict response to treatment in patients with rheumatoid arthritis.

Authors
Type
Published Article
Journal
Annals of the rheumatic diseases
Publication Date
Volume
64
Issue
4
Pages
569–574
Identifiers
PMID: 15345501
Source
Medline

Abstract

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments